Skip to main
MCS
MCS logo

Marcus (MCS) Stock Forecast & Price Target

Marcus (MCS) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 20%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Marcus Corp's positive outlook is supported by a significant 26% increase in the full-year box office, despite a 300-basis point headwind from the early quarter-end. The company's estimated revenue is projected to grow by 8.2% to $150 million, primarily driven by the theatre segment, which benefits from a forecasted increase in wide film releases by 15.8% in 2025. Additionally, a total EBITDA of $25.9 million, reflecting a year-over-year increase of 42%, along with RevPAR growth of 3.6% that outperformed industry averages, further bolsters the financial health of Marcus Corp.

Bears say

Marcus Corp faces significant challenges, primarily due to a considerable decline in box office performance, with April and May 2024 figures down approximately 40% compared to 2023. The company's Hotels and Resorts segment has also shown year-over-year profit decreases, echoing concerns highlighted during previous economic downturns, such as the 2008-09 recession. Furthermore, the company reported choppy segment profits and took impairment charges on certain theatre properties, indicating underlying financial instability and potential difficulties in future performance.

Marcus (MCS) has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 20% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Marcus and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Marcus (MCS) Forecast

Analysts have given Marcus (MCS) a Buy based on their latest research and market trends.

According to 5 analysts, Marcus (MCS) has a Buy consensus rating as of Jul 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Marcus (MCS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.